Search results
Uniquity Bio launches to focus on immunology and inflammation
Pharmaceutical Technology via Yahoo Finance· 5 hours agoof June 2024. The antibody was in-licensed from Merck. With financial backing from Blackstone...
Israel’s Once-Dominant Drugmaker Is Revived by Innovation
The Wall Street Journal via Yahoo Finance· 2 days agoLast year, Merck agreed to pay $10.8 billion for a drug in the same category, yet right now...
Cinven to explore $3 billion sale of software maker Jaggaer, sources say
Reuters via Yahoo News· 3 days agoPrivate equity firm Cinven is preparing to explore a sale of Jaggaer that it hopes will value the maker of supply chain software at about $3 billion, including ...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 6 days agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
Veeva and H&E Equipment Services have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 3 days ago“We believe the easing in the progression of construction spending is in part the result of a...
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting
WPRI Providence· 3 days agoAstellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will share new research from across its innovative portfolio of approved ...
Why Lilly And Novo Nordisk Will Keep Dominating The Market For Blockbuster GLP-1 Drugs
Forbes· 1 day agoThe mass interest in GLP-1 drugs has led to a business boom for the two dominant pharmaceutical...